Descriptor in English: | Prazosin |
Descriptor in Spanish: | Prazosina |
Descriptor in Portuguese: | Prazosina |
Descriptor in French: | Prazosine |
Entry term(s): |
Furazosin HCL, Prazosin Hydrochloride, Prazosin Minipress Pratsiol Prazosin HCL Prazosin Hydrochloride |
Tree number(s): |
D03.633.100.786.750 |
Scope note: | A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. |
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
History Note: | 86(77); was see under QUINAZOLINES 1977-85 |
DeCS UI: | 22618 |
Descriptor UI: | D011224 |
Date Established: | 1986/01/01 |
Date of Entry: | 1976/04/13 |
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Prazosin
- Preferred
Prazosin Hydrochloride
- Narrower
Minipress
- Narrower
Pratsiol
- Narrower
Concept UI |
M0017441 |
Scope note | A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. |
Preferred term | Prazosin |
Entry term(s) |
Furazosin |
Concept UI |
M0544014 |
Preferred term | Prazosin Hydrochloride |
Entry term(s) |
HCL, Prazosin Hydrochloride, Prazosin Prazosin HCL |
Concept UI |
M0017442 |
Preferred term | Minipress |
Concept UI |
M0017440 |
Preferred term | Pratsiol |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey